WOUND CARE FORMULATION

Paul McCarron; Mark Jenkins; Ryan Loughlin

WOUND CARE FORMULATION

Paul McCarron (Inventor), Mark Jenkins (Inventor), Ryan Loughlin (Inventor)

n/a

Research output: Patent

Abstract

A gel formulation for use in filling a wound cavity and delivering active ingredient thereto, having a pH range of 6.5 to 7.5, low bioadhesive strength and cohesive integrity and being a PVA borate gel including an active ingredient and a modulator to bind borate and/or PVA in aqueous solution through a mono-diol or di-diol formation and reduces the pH of PVA-borate hydrogels. A suitable modulator is a sugar alcohol such as mannitol and the active ingredient, a medicament suitable for topical application such as a local anaesthetic and/or an antibiotic.

Original language	English
Patent number	12/733,776
Priority date	1/03/16
Publication status	Published (in print/issue) - 1 Mar 2016

Keywords

n/a

Cite this

@misc{60703b75d5674eed8baec0199cbed5f7,

title = "WOUND CARE FORMULATION",

abstract = "A gel formulation for use in filling a wound cavity and delivering active ingredient thereto, having a pH range of 6.5 to 7.5, low bioadhesive strength and cohesive integrity and being a PVA borate gel including an active ingredient and a modulator to bind borate and/or PVA in aqueous solution through a mono-diol or di-diol formation and reduces the pH of PVA-borate hydrogels. A suitable modulator is a sugar alcohol such as mannitol and the active ingredient, a medicament suitable for topical application such as a local anaesthetic and/or an antibiotic.",

keywords = "n/a",

author = "Paul McCarron and Mark Jenkins and Ryan Loughlin",

year = "2016",

month = mar,

day = "1",

language = "English",

type = "Patent",

note = "12/733,776",

}

TY - PAT

T1 - WOUND CARE FORMULATION

AU - McCarron, Paul

AU - Jenkins, Mark

AU - Loughlin, Ryan

PY - 2016/3/1

Y1 - 2016/3/1

N2 - A gel formulation for use in filling a wound cavity and delivering active ingredient thereto, having a pH range of 6.5 to 7.5, low bioadhesive strength and cohesive integrity and being a PVA borate gel including an active ingredient and a modulator to bind borate and/or PVA in aqueous solution through a mono-diol or di-diol formation and reduces the pH of PVA-borate hydrogels. A suitable modulator is a sugar alcohol such as mannitol and the active ingredient, a medicament suitable for topical application such as a local anaesthetic and/or an antibiotic.

AB - A gel formulation for use in filling a wound cavity and delivering active ingredient thereto, having a pH range of 6.5 to 7.5, low bioadhesive strength and cohesive integrity and being a PVA borate gel including an active ingredient and a modulator to bind borate and/or PVA in aqueous solution through a mono-diol or di-diol formation and reduces the pH of PVA-borate hydrogels. A suitable modulator is a sugar alcohol such as mannitol and the active ingredient, a medicament suitable for topical application such as a local anaesthetic and/or an antibiotic.

KW - n/a

M3 - Patent

M1 - 12/733,776

ER -

WOUND CARE FORMULATION

Abstract

Keywords

Fingerprint

Cite this